Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,025.16 888.01 223.31 -168.96 40.15 0.03 16.3553 -0.36 -113.5235 -2,342.3822 -9.30 -9.19 689.6235 - -
Maximum - - - - - - 593,737.00 65,349.00 25,407.00 99,050.00 5,305.00 0.94 1,336.3467 6.70 300.5100 8,534.8500 38.40 835.37 3,719.5300 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -10,177.5800 -144,478.0000 -155.91 -1,263.79 0.0700 - -
Vaxcyte, Inc. PCVX 117.12 0.58 0.50% 983 vs. 1,024 14,265.00 0.00 -95.00 -171.00 -1,019.00 -0.8500 -19.6094 0.00 0.00 0.00 -4.79 -4.54 1724.98 121.00
Chinook Therapeutics, Inc. KDNY 40.39 0.09 0.22% 3,281 vs. 2,044 2,708.00 1.00 -66.00 -61.00 -546.00 -0.9400 -10.2719 0.00 57.04 -6641.27 -18.75 -13.70 572.24 67.00
Karuna Therapeutics, Inc. KRTX 329.83 0.09 0.03% 1,283 vs. 971 12,599.00 0.00 -113.00 -111.00 -997.00 -3.0100 -26.2644 0.00 0.00 0.00 -9.08 -8.52 1860.75 38.00
MoonLake Immunotherapeutics MLTX 53.71 0.60 1.13% 289 vs. 332 3,377.00 0.00 -13.00 -15.00 -130.00 -0.2200 -55.6575 0.00 0.00 0.00 -2.52 -2.42 6156.21 62.00
DICE Therapeutics, Inc. DICE 47.55 0.03 0.06% 4,332 vs. 1,753 2,270.00 0.00 -34.00 -30.00 -248.00 -0.7400 -15.7831 0.00 0.00 0.00 -6.71 -6.32 2568.58 47.00
Nuvalent, Inc. NUVL 103.25 0.62 0.60% 866 vs. 423 7,206.00 0.00 -44.00 -36.00 -330.00 -0.6900 -27.7942 0.00 0.00 0.00 -6.59 -6.28 2069.70 69.00
Cytokinetics, Incorporated CYTK 55.60 -0.34 -0.61% 2,619 vs. 1,406 6,541.00 0.00 -135.00 -127.00 -2,247.00 -1.3300 -13.7171 0.00 -179.16 -16244.67 34.24 -16.79 697.96 117.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for DICE and its peers to uncover potential buy and sell opportunities.